Yu Xiao

1.3k total citations
34 papers, 583 citations indexed

About

Yu Xiao is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Yu Xiao has authored 34 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in Yu Xiao's work include Herpesvirus Infections and Treatments (4 papers), MicroRNA in disease regulation (3 papers) and Mass Spectrometry Techniques and Applications (3 papers). Yu Xiao is often cited by papers focused on Herpesvirus Infections and Treatments (4 papers), MicroRNA in disease regulation (3 papers) and Mass Spectrometry Techniques and Applications (3 papers). Yu Xiao collaborates with scholars based in China, United States and Netherlands. Yu Xiao's co-authors include Shaoping Li, Yitao Wang, Guang Hu, Feng Yang, Simon Ming‐Yuen Lee, Hang Yin, Liangliang Liu, Yanli Liu, Xiaochun Bai and Haiyan Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and ACS Nano.

In The Last Decade

Yu Xiao

33 papers receiving 578 citations

Peers

Yu Xiao
Comparison fields: 5 of 84
  • Molecular Biology 300
  • Immunology 110
  • Cancer Research 91
  • Oncology 86
  • Epidemiology 75
Replace Guoqing Hou with:
Guoqing Hou China
Chieh‐Shan Wu Taiwan
Yuhua Su China
Peng Lyu China
Zhizhong Zheng China
Saeed Mohammadi Iran
Rui Han China
Weiran Wang China
Rupert L. Mayer Austria
Pengyu Liu China
Guoqing Hou China View profile →
Citations per field, relative to Yu Xiao
Yu Xiao · 1×
Citations per year, relative to Yu Xiao
Yu Xiao · 1×

Countries citing papers authored by Yu Xiao

Since Specialization
Citations

This map shows the geographic impact of Yu Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Xiao more than expected).

Fields of papers citing papers by Yu Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Xiao. The network helps show where Yu Xiao may publish in the future.

Co-authorship network of co-authors of Yu Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Xiao. A scholar is included among the top collaborators of Yu Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Xiao. Yu Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 5
3 1
4 3
5 15
6 9
7 24
8 17
9 1
10 79
11 6
12 89
13 57
14
Effects of advanced glycation end products on the expression of urotensin II in rat NRK-52E cells
0
15 11
16 13
17 4
18 14
19 10
20 11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026